Emcure Pharma Declares Unaudited Q1 FY27 Results

Emcure Pharmaceuticals Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results, which were reviewed and recommended by the Audit Committee. The company submitted the results along with Limited Review Reports from statutory auditors B S R & Co. LLP, as per SEBI Listing Regulations. A press release detailing key updates on these results was also enclosed.